286
landing page
MI Health
MI Health bridges innovation gaps across the health and health-care continuum. We advance whole-pers
on health throughout the life span by improving healthy aging, public health, biomedical science, and food systems., Future of Health Summit Panels
The Milken Institute Future of Health Summit brought together hundreds of leaders from across sectors to discuss critical issues and solutions within reach for ,
,
+ Read More
landing page
Frontotemporal Dementia
Frontotemporal Dementia
Frontotemporal dementia (FTD) describes brain conditions characterized by p
rogressive degeneration of the brain’s frontal and temporal lobes., About the Kissick Family Foundation FTD Grant Program
The Kissick Family Foundation partnered with MI Philanthropy’s Science and Health team in 2022 to analyze and understand the state of the FTD research ecosystem and identify where phi,
, Please
+ Read More
landing page
Livestream | 2023 Future of Health Summit
Looking for a session? Scroll down this page to find it. Looking for Program details? Find them
here.
+ Read More
landing page
Science Philanthropy Accelerator for Research and Collaboration
Who We Are
$30 billion in philanthropic funds are spent annually to advance medical research for tr
eatments and cures., Partner with Us
Leverage our strategic advisory service, scientific experts, and the breadth of the Milken Institute network to ensure your philanthropic resources advance medical solutions.
+ Read More
landing page
Center for Public Health Advisory Board
Paul Chew
President, 1Rx DigiPharm Advisory, LLC
report
Learning from COVID-19: Reimagining Public-Private Partnerships in Public Health
The Milken Institute Center for Public Health leveraged our network of thought leaders to maximize
learnings from the COVID-19 pandemic, focused on examining the private sector’s role and responsibility in supp
+ Read More
report
Strengthening the Biomedical Innovation Ecosystem: A Scorecard for System Assessment
As patients, we often evaluate our interactions within the "system" of biomedical innovation with a
simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and available, how the
+ Read More
report
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially c
ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.
+ Read More
report
Capital Markets in Rwanda: Assessment and Aspirations
In 2015, the Rwandan Ministry of Finance and Economic Planning mandated the Capital Market Authorit
y (CMA) of Rwanda to develop a Capital-Market Master Plan (CMMP). This plan will set the CMA’s policy strategy for the next 10 years.
+ Read More
report
Can Stock Exchanges Support the Growth of Small and Medium-Sized Enterprises? Lessons from India, South Africa, and Jamaica
Despite their importance in creating private-sector jobs and diversifying economies, small to mediu
m-sized enterprises (SMEs) often struggle to access adequate finance.
+ Read More
report
The Price Women Pay for Dementia: Strategies to Ease Gender Disparity and Economic Costs
Technical Update
report
Financing the Control of Tuberculosis
As of 2015, roughly one third of the world’s population, mostly in poorer countries, carried tuberc
ulosis bacteria in their system. Given the characteristics of airborne diseases like tuberculosis, coordination among national and international age
+ Read More